Drug Trial Radar · NCT03789656
An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)
Last checked: Nov 20, 2026Latest source record: Feb 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
47
Actual
Start
Mar 12, 2019
Primary completion
Aug 3, 2020
Study completion Aug 31, 2020
Sponsor
- Lead sponsor
- Crinetics Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 28, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An open label exploratory study designed to evaluate the safety, efficacy, and pharmacokinetics of paltusotine (formerly CRN00808) in subjects with acromegaly that are treated with somatostatin analogue (SSA) based treatment regimens.
Conditions
- Acromegaly
Interventions
PaltusotineDrug
Paltusotine, capsules, once daily by mouth
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline (Median of Screening Values) in Insulin-like Growth Factor-1 (IGF-1) LevelTime frame: 13 Weeks
Locations
26 sites in 12 countries. Site status is shown where the registry gives one.
UCLA Gonda Diabetes Center
Los Angeles, California
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Massachusetts General Hospital
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
OHSU Northwest Pituitary Center
Portland, Oregon
Allegheny Endocrinology Associates
Pittsburgh, Pennsylvania
CETI - Centro de Estudos em Terapias Inovadoras
Curitiba, Brazil
Hospital Universitário Clementino Fraga Filho (HUCFF/UFRJ) Centro de Pesquisa em Neuroendocrinologia
Rio de Janeiro, Brazil
CPQuali Pesquisa Clinica
São Paulo, Brazil
LMU Clinic of University of Munich
Munich, Germany
General Hospital of Athens "Evangelismos"
Athens, Greece
General Hospital of Athens "Gennimatas"
Athens, Greece
General Hospital of Athens "Laiko"
Athens, Greece
General Hospital of Athens "Ippokratio"
Thessaloniki, Greece
Military Health Center, Division of Endocrinology
Budapest, Hungary
Semmelweis University Faculty of Medicine
Budapest, Hungary
University of Pécs Medical School
Pécs, Hungary
Azienda Ospedaliera Universitaria Federico II
Naples, Italy
Waitemata District Health Board, North Shore Hospital
Takapuna, New Zealand
Endocrine, Diabetes and Research Centre, Wellington Hospital
Wellington, New Zealand
Clinic of Endocrinology Independent Public Health Care Centre University Hospital in Kracow
Krakow, Poland
National Institute of Endocrinology "C. I. Parhon"
Bucharest, Romania
Clinical Centre Serbia, Clinic for Endocrinology, Diabetes and Metabolic Diseases
Belgrade, Serbia
University Hospital Bratislava
Bratislava, Slovakia
University Hospitals Coventry and Warwickshire NHS Trust
Coventry, United Kingdom
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.